Hester Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	30.73	59.65	127.48	131.56	247.5
Short-Term Investments	-	34.65	12.54	25.56	16.61	4.53
Cash & Short-Term Investments	65.38	65.38	72.19	153.04	148.17	252.03
Cash Growth	-9.43%	-9.43%	-52.83%	3.29%	-41.21%	18.50%
Accounts Receivable	-	953.56	731.81	786.45	796.31	552.8
Other Receivables	-	84.78	69.08	57.85	59.97	17.63
Receivables	-	1,039	858.45	902.86	916.18	631.23
Inventory	-	725.33	703.77	755.81	848.1	753.82
Prepaid Expenses	-	11.01	16.8	12.72	12.83	23.9
Other Current Assets	-	244.49	300.53	321.72	350.64	286.65
Total Current Assets	-	2,086	1,952	2,146	2,276	1,948
Property, Plant & Equipment	-	4,111	4,094	4,076	4,050	3,170
Long-Term Investments	-	429.69	356.65	306.64	267.31	241
Other Intangible Assets	-	97.22	66.57	39.32	29.36	20.44
Other Long-Term Assets	-	56.26	65.36	55.53	76.68	242.17
Total Assets	-	6,779	6,534	6,623	6,700	5,622
Accounts Payable	-	246.8	294.19	258.56	299.77	180.18
Accrued Expenses	-	168.78	90.45	21.37	29.65	16.27
Short-Term Debt	-	242.86	295.79	313.51	588.58	348.45
Current Portion of Long-Term Debt	-	740.05	448.28	389.24	243.17	230.65
Current Portion of Leases	-	2.28	-	0.42	5	4.44
Current Income Taxes Payable	-	50.02	40.17	24.56	33.95	9.38
Current Unearned Revenue	-	39.18	5.04	5.04	12.73	-
Other Current Liabilities	-	34.81	77.92	42.02	274.11	179.6
Total Current Liabilities	-	1,525	1,252	1,055	1,487	968.97
Long-Term Debt	-	899.64	1,334	1,820	1,848	1,644
Long-Term Leases	-	63.11	54.75	53.78	56.69	54.4
Long-Term Unearned Revenue	-	502.55	540.16	543.81	329.64	202.74
Pension & Post-Retirement Benefits	-	-	3.74	2.64	2.16	2.34
Long-Term Deferred Tax Liabilities	-	88.08	59.33	74.11	73.51	65.1
Other Long-Term Liabilities	-	23.36	23.79	45.22	17.16	10.38
Total Liabilities	-	3,102	3,267	3,595	3,814	2,948
Common Stock	-	85.07	85.07	85.07	85.07	85.07
Additional Paid-In Capital	-	175.07	175.07	175.07	175.07	175.07
Retained Earnings	-	3,260	2,763	2,543	2,423	2,240
Comprehensive Income & Other	-	82.67	119.29	114.64	114.48	99.33
Total Common Equity	3,602	3,602	3,143	2,918	2,797	2,600
Minority Interest	-	75.54	124.01	110.82	88.16	74.09
Shareholders' Equity	3,678	3,678	3,267	3,029	2,885	2,674
Total Liabilities & Equity	-	6,779	6,534	6,623	6,700	5,622
Total Debt	1,948	1,948	2,133	2,577	2,742	2,282
Net Cash (Debt)	-1,883	-1,883	-2,060	-2,424	-2,593	-2,030
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-218.47	-221.30	-242.19	-284.99	-304.85	-238.59
Filing Date Shares Outstanding	8.53	8.51	8.51	8.51	8.51	8.51
Total Common Shares Outstanding	8.53	8.51	8.51	8.51	8.51	8.51
Working Capital	-	560.84	699.9	1,091	788.96	978.66
Book Value Per Share	423.46	423.46	369.41	343.01	328.83	305.62
Tangible Book Value	3,505	3,505	3,076	2,879	2,768	2,579
Tangible Book Value Per Share	412.04	412.04	361.59	338.39	325.38	303.22
Land	-	83.54	136.36	136.36	136.36	102.62
Buildings	-	1,987	1,552	1,554	1,594	1,396
Machinery	-	3,704	2,141	2,053	2,059	1,921
Construction In Progress	-	-	1,767	1,681	1,461	802.24